Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Generate Biomedicines

Explore full profile

Pioneering Generative Biology to create breakthrough medicines

Somerville, United StatesFounded 2020Biotech & Life Sciences
Valuation $2.04B Market cap · Feb/2026
Revenue $26M Latest reported FY

At a glance

Status
Listed
Founded
2020
Headquarters
Somerville, United States
Listing
IPO 2026
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierColt$25–100M revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
News MiRABO Biotechnology raises $2.9M pre-Series A for its antibody drug AI Aug 20, 2026 Market map Peptides: The Next Drug Modality Stack Apr 10, 2026

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later14 investors entered at this stage

Talent

Book a demo to see the people
Employees mapped 334 incl. 26 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 29 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former Generate Biomedicines employees who went on to found companies, sorted by Dealroom signal score.

Lila SciencesEst. 2022
Geoffrey von MaltzahnUnited States
Signal score97
AbiologicsEst. 2020
Avak KahvejianUnited States
Signal score90
Gate BioscienceEst. 2021
JMJordi Mata-FinkUnited States
Signal score76
Montai HealthEst. 2022
Noubar AfeyanUnited States
Signal score68
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States98.8%
🇦🇪 United Arab Emirates0.4%
🇬🇧 United Kingdom0.4%
🇨🇦 Canada0.4%
🇨🇳 China0.4%
5 countries shown
Web traffic by country
19K monthly visits
across markets
🇺🇸 United States77.9%
🏳️ Korea4.7%
🏳️ Republic of4.2%
🇮🇳 India4.2%
🇬🇧 United Kingdom3.2%
Top 5 markets shown

Patents

Estimated portfolio value
$396k

8 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Generate Biomedicines on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Generate Biomedicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles